HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic combo shows promise for cancer patients with dangerous fevers
Disease control CompletedThis study tested a new antibiotic combination (imipenem-relebactam) against standard antibiotics for treating fever caused by low white blood cells in 100 adults with cancer. The goal was to see if the new drug works as well or better at controlling infections. Results help doct…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
New Two-Step transplant shows promise against tough blood cancers
Disease control CompletedThis study tested a two-step donor stem cell transplant in 51 people with high-risk blood cancers. The approach uses radiation and chemo before the transplant to prepare the body, then donor stem cells to rebuild healthy blood and attack remaining cancer. The goal was to improve …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Can a single infusion protect kidneys during cancer treatment?
Disease control CompletedThis study tested the drug pegloticase in 10 cancer patients with high uric acid levels caused by tumor lysis syndrome, a complication where dying cancer cells release substances that can damage the kidneys. The goal was to see if pegloticase could quickly lower uric acid and pro…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug combo may reduce transplant complications in blood cancer patients
Disease control CompletedThis study tested different combinations of immune-suppressing drugs to prevent graft-versus-host disease (GVHD) in 174 patients with blood cancers who received a stem cell transplant from an unrelated donor. The goal was to find the most effective approach to reduce severe GVHD,…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Digital symptom tracking may ease cancer patients' daily struggles
Symptom relief CompletedThis study tested whether using electronic health records to track and manage common cancer symptoms—such as pain, fatigue, sleep problems, anxiety, and depression—can improve quality of life and reduce hospital visits. Over 50,000 cancer patients took part. The goal was to see i…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 02:43 UTC
-
Can kindness and gratitude boost cancer Patients' Well-Being?
Symptom relief CompletedThis study tested whether doing simple positive activities, like helping with household chores or writing a thank-you letter, can improve quality of life for cancer patients from collectivist cultures (e.g., Latino, Asian American, African American). 75 patients and their caregiv…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 02:26 UTC
-
Rose geranium spray offers nose relief for chemo patients
Symptom relief CompletedThis study tested whether a rose geranium and sesame oil nasal spray can improve nose symptoms like dryness, discomfort, bleeding, or scabbing in cancer patients receiving chemotherapy. About 106 adults with these symptoms took part. The spray was compared to a plain saline spray…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 02:25 UTC
-
Smartwatches and apps could transform cancer care monitoring
Knowledge-focused CompletedThis study tested if wearable devices and smartphone apps can better track cancer patients' vital signs and symptoms than standard in-person checks. About 100 adults with various cancers used a device and app at home. The goal was to see if remote monitoring can detect problems l…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC
-
New study tracks transplant patients to predict a common complication
Knowledge-focused CompletedThis study followed 267 adults who had stem cell transplants to understand why some develop chronic graft-versus-host disease (GVHD), a long-term complication. Researchers collected blood, saliva, and eye fluid samples and performed exams to track early signs. The goal was to lea…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:39 UTC
-
New tool aims to predict chemo risks for older cancer patients
Knowledge-focused CompletedThis study looked at 182 older adults with blood cancer or lung cancer to see if a special calculator could predict who would have severe side effects from chemotherapy. Researchers measured patients' fitness before and after treatment. The goal is to help doctors choose safer tr…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:25 UTC
-
New program aims to ease cancer survivors' distress and improve follow-up care
Knowledge-focused CompletedThis study tested a program designed to help adolescent and young adult cancer survivors (ages 15-39) find and use healthcare resources after treatment. The goal was to improve their health knowledge, self-care skills, and support, and to reduce cancer-related distress. 549 survi…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Personalized plans may boost transplant survival in seniors
Knowledge-focused CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 patients aged 60 and older who were getting a stem cell transplant for blood cancers or bone marrow failure. The plan included tailored changes to diet, sleep, activity, and medications. The goal was to see …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC
-
Study uses wearable socks to predict chemo fall risks
Knowledge-focused CompletedThis study looked at how chemotherapy affects symptoms, daily function, and falls in 200 cancer patients aged 40-85. Researchers used questionnaires and wearable devices like instrumented socks and activity trackers to find simple ways to predict when patients are at higher risk …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC
-
Cancer sepsis study: do stronger antibiotics speed recovery?
Knowledge-focused CompletedThis study looked at whether adding a type of antibiotic called aminoglycosides helps cancer patients with sepsis and low blood pressure recover faster. Researchers compared patients who got these extra antibiotics to those who did not. The main goal was to see how quickly blood …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC
-
New program helps doctors tackle cancer Survivors' unique health needs
Knowledge-focused CompletedThis study tested a training program for community healthcare providers to improve their knowledge and skills in caring for cancer survivors. Twenty-eight providers from five Ohio hospitals participated. The program aimed to help doctors better understand survivors' long-term hea…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:15 UTC